Replies to post #324439 on Avid Bioservices Inc (CDMO)

[biopharm]

salvaging something out of nothing...

Who is buying that ? We all know the value behind PS Targeting /trials / data Biomarkers etc have been suppressed at each and every attempt to move forward

It is statistically impossible for all these events to take place and shareholders paid for the research and data ....the same research and data that is being hidden from us now

Pretty sad when Residual Value Renegade Roger Lias has no clue why Precision For Medicine buys out Epiontis and makes no mention of Thomas O Kleen

https://www.linkedin.com/in/thomasokleen

Wonder what is discussed on Feb 13 2018 at noon time

Combo IO therapies and you think the monitoring of systemic changes in the blood and TILs important ? Probably just residual important if one asked Roger and all BODs that failed their Fiduciary Duties to PPHM CDMO shareholders

I don't see how a lawsuit is not filed as all Biomarker info / patents etc just ignored and left for another party to cash in

[DrRocker]

At this point we don't know whether we are being screwed or whether someone is salvaging something out of nothing...

Could be both.
I would love to know who is behind the $8 million in upfront money and would not be surprised it if was Dart's crew.

I am hopeful that the Ronin team has real interest in developing Avid and was not just brought in to steal the IP for bread crumbs.

[geocappy1]

$180M? We also don't know if they will really develop the IP so the deal could $8+0+0=$8M

I would think if it were a real deal we would see more info. Maybe somebody just spent $8M to bury the PS patents. Companies have spent more to bury technology

[geocappy1]

Here is a question for your sources. What are we entitled to if Oncoloie sells our BP to BP for $100.